- Report
- June 2024
- 108 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- October 2024
- 185 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 195 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 120 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- March 2025
- 181 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- August 2024
- 136 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- April 2024
- 137 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- August 2024
- 200 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- May 2024
- 191 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- July 2024
- 178 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- December 2024
- 150 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- December 2024
- 470 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- November 2024
- 997 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- November 2024
- 799 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- April 2024
- 505 Pages
Global
€2326EUR$2,450USD£1,962GBP
- Report
- September 2024
- 165 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- July 2024
- 639 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- November 2024
- 207 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- April 2024
- 74 Pages
Global
From €4414EUR$4,650USD£3,724GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more